Form D · Private Equity Fund

Blackstone Life Sciences V L.P.

New York, NY · CIK 0001797712

Offering snapshot reported Jul 9, 2020 · SEC filing

Reported sold
$4.61B
Offering amount: $4.61B
Investors reported
102
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
Dec 31, 2019
As reported in this filing

Fundraising history

Reported sold
Reported amount sold by Form D filing date$0$2.3B$4.61BJan 9, 2020: $3,444,130,000.00Jan 9, 2020Feb 7, 2020: $3,444,130,000.00May 13, 2020: $4,202,370,000.00May 13, 2020Jul 9, 2020: $4,605,000,000.00Jul 9, 2020

Dates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.

What changed?

Latest filing versus its linked predecessor, where available.

  • Reported sold$4,202,370,000 → $4,605,000,000
  • Reported investors99 → 102

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Jul 9, 2020Amendment$4,605,000,000$402,630,000vs May 13, 2020102SEC filing
May 13, 2020Amendment$4,202,370,000$758,240,000vs Feb 7, 202099SEC filing
Feb 7, 2020Amendment$3,444,130,000$0vs Jan 9, 202086SEC filing
Jan 9, 2020Initial$3,444,130,000No comparison86SEC filing

Offering details

Securities
Pooled investment fund
Exemptions
06b, 3C, 3C.7
Duration over one year
No
Business combination
No
Sales commissions
$18.2M (estimated)
Finders' fees
$0
Form D file number
021-357589
Total offering amount and total amount sold includes the General Partner's commitment as well as sales in parallel funds.

Sales compensation recipients

Scroll to see all columns →

RecipientCRDAssociated broker-dealer
Morgan Stanley Smith Barney LLC149777
Compass Group Global Advisors S.A.None
Snowbridge Securities LLC301996
Korea Investment & Securities Co., Ltd.None
UBS Financial Services Inc.8174
Merrill Lynch, Pierce, Fenner & Smith Incorporated7691

Source: Form D, filed Jul 9, 2020. Minimum accepted may differ from a standard advertised minimum.

Fund connections

The linked fund shows its most recently reported ADV details.

Matched by reported Form D file number

BLACKSTONE LIFE SCIENCES V L.P.

Investment adviser: BLACKSTONE LIFE SCIENCES ADVISORS L.L.C.

Gross asset value
$6.59B
Beneficial owners
107
ADV minimum commitment
$10M

Reported in Form ADV on Mar 30, 2026. Fund assets and beneficial owners measure different things from Form D sales and investors.

Service providers

Auditor DELOITTE & TOUCHE LLP NEW YORK, New York, United States
Custodian BANK OF AMERICA, N.A WILMINGTON, Delaware, United States Related to adviser: No
Custodian CITIBANK, N.A. LONDON, United Kingdom Related to adviser: No
Custodian JPMORGAN CHASE BANK, N.A. NEW YORK, New York, United States Related to adviser: No
Custodian UBS FINANCIAL SERVICES INC. BOSTON, Massachusetts, United States Related to adviser: No
Provider details
Annual audit
Yes
Prime brokers
No
Custodians
Yes
Administrator other than the adviser
No
External marketing
No

DELOITTE & TOUCHE LLP
PCAOB 34

Filing source

Form ADV 2068503 · Mar 30, 2026 · Schedule D 7.B.(1), fund 805-3129550239

Official IAPD profile (latest public filing). Values are the most recently reported in our imported data; the public profile may show a newer filing.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Joseph Baratta Executive
N/A N/A Blackstone Life Sciences Associates V L.P. Promoter
N/A N/A Bxls V L.L.C. Promoter
John G. Finley Executive
Nick Galakatos Executive
Robert Liptak Executive
Christopher Placca Executive
Omar Rehman Executive
Matthew Skurbe Executive
Christopher Striano Executive

Issuer details

Industry: Pooled Investment Fund (See others in industry)

Address:
345 Park Avenue
New York, NY, 10154